Yeah but my point was that if the market has doubts about revenue projections then FDA approval by itself is no guarantee of SP bounce.
I agree that AVH management had given the market reason to doubt their revenue projections and that is not yet the case with BOT, so the situations may be different.
AVH introduced a new medical device.
BOT - Anything but charting, page-8693
-
- There are more pages in this discussion • 1,000 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 782479 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |